Riskpilot← Back to searchSign inGet full accessMG Psykoterapi AB
ABActiveOrg 5590111646Sickla Industriväg 10Wholesale of beverages · NACE 4634Est. 20150 employees
Revenue 2024
SEK 461K
-30% vs 2023
EBITDA margin
78.3%
-34% vs 2023
Equity ratio
96.3%
Financial strength
Net profit 2024
SEK 305K
-31% vs 2023
| Revenue | SEK 461K | -30% |
| EBITDA | SEK 361K | -34% |
| Net profit | SEK 305K | -31% |
| Total assets | SEK 2,1M | +5% |
| Equity | SEK 2,1M | +5% |
| Employees | 0 | — |
Legal name
MG Psykoterapi AB
Org number
5590111646
Legal form
Aktiebolag
NACE code
4634 · Wholesale of beverages
Founded
20 april 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva psykoterapibehandling , föreläsning och utbildningsverksamhet samt förvaltning av värdepapper samt idka därmed förenlig verksamhet.
Address
Sickla Industriväg 10
Email
gunnar@conturkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 865 | 846 | 880 | 656 | 461 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 702 | 699 | 748 | 545 | 361 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 702 | 699 | 748 | 545 | 361 |
| Net financials | — | 9 | 5 | 3 | 24 |
| Profit before tax | 702 | 708 | 752 | 556 | 385 |
| Tax | −150 | −146 | −155 | −115 | −80 |
| Net profit | 552 | 562 | 597 | 441 | 305 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 217 | 1 662 | 1 820 | 2 030 | 2 136 |
| Equity | 931 | 1 302 | 1 709 | 1 952 | 2 058 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 286 | 360 | 111 | 78 | 78 |
| Total debt | 286 | 360 | 111 | 78 | 78 |
EBITDA margin
78.3%
This company
15.8%
Market median
+396% vs market
20202024
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
66.2%
This company
8.1%
Market median
+717% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MG Psykoterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Göransson | Board of Directors | 0 companies |
| Per Anders Gunnar Göransson | Deputy Board Member | 0 companies |